SEI Enhanced U.S. Large Cap Momentum Factor ETF (SEIM)
Live price chart, market sentiment, and community perspectives for SEI Enhanced U.S. Large Cap Momentum Factor ETF (CBOE: SEIM).
Live price chart, market sentiment, and community perspectives for SEI Enhanced U.S. Large Cap Momentum Factor ETF (CBOE: SEIM).
On our desk, the recent July 2026 price action for SEIM is fascinating. While momentum indexes got crushed, SEIM's quantitative model mitigated some of the extreme drawdown compared to its peer group, dropping -7.82% versus the peer average of -14.46%. However, looking at the institutional data from Q2, we notice a slight cooling in broad participation—while 72 funds still hold $1.03B, overall fund ownership dropped about 4.4% to 68.82%, with more reductions than new repeat investments. Market sentiment remains cautious because, despite competitive positioning, it is treated more as a specialized tactical tool than a core alpha generator.
Reviewing the underlying risk factors of SEIM, my primary concern is the extreme concentration risk. Over 50% of the portfolio is funneled directly into AI-related companies, creating a high-beta growth profile that leaves the fund vulnerable to sudden factor reversals. While the expense ratio is very competitive at 0.15% and the 1-year trailing change is robust at over 37%, the structural reality of low liquidity, average volume under 80,000 shares, and wider bid/ask spreads means execution costs can easily eat into your factor alpha if you're managing larger sizing.
From a quantitative and portfolio construction perspective, SEIM's process pillar focuses heavily on blending price momentum with rising earnings using QiM's rules-based active methodology. When evaluating this for a multi-factor sleeve, you have to weigh its structural features carefully. It holds roughly $1.43B in total assets with a 52-week range spanning from 40.04 to 55.69. If you are questioning candidates about active factor ETFs, make sure to highlight how SEIM handles high-volatility stock exposure differently during market selloffs, shielding investors from maximum drawdowns while still maintaining aggressive upside factor tilt.
Explore plasma cleansing, somatic organ swaps, and BCI.